Current Report Filing (8-k)
February 24 2021 - 3:55PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): February 18, 2021
BIOSOLAR, INC.
(Exact name of registrant as specified in
its charter)
|
Nevada
|
|
000-54819
|
|
20-4754291
|
|
(State or other jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer
|
|
of incorporation)
|
|
|
|
Identification No.)
|
27936 Lost Canyon Road, Suite 202,
Santa Clarita, CA 91387
(Address of principal executive offices
and Zip Code)
Registrant’s telephone number, including
area code: (661) 251-0001
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
|
|
☐
|
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title
of each class
|
|
Ticker
symbol(s)
|
|
Name
of each exchange on which registered
|
|
N/A
|
|
N/A
|
|
N/A
|
Indicate by check
mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter).
Emerging growth company ☐
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.01 Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 18, 2021 the
board of directors of BioSolar, Inc. (the “Company”) granted David Lee an option to purchase 400,000,000 shares of
the Company’s common stock. Half of the Option is immediately exercisable and the remaining half of the Option will become
vested and exercisable on a monthly basis over two years with the first vesting on March 18, 2021, and shall be exercisable at
a price of $0.091.
On February 18, 2021 the board of directors
of BioSolar, Inc. (the “Company”) granted Spencer Hall an option to purchase 50,000,000 shares of the Company’s
common stock and will become vested and exercisable on a monthly basis over three years with the first vesting on March 18, 2021,
and shall be exercisable at a price of $0.091.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
BIOSOLAR, INC.
|
|
|
|
|
Date: February 24, 2021
|
/s/ David Lee
|
|
|
David Lee
|
|
|
Chief Executive Officer
|
2